SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZFHX3
|
ENSG00000140836.10 | zinc finger homeobox 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZFHX3 | hg19_v2_chr16_-_73093597_73093597 | 0.25 | 2.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_155511887 | 3.01 |
ENST00000302053.3
ENST00000403106.3 |
FGA
|
fibrinogen alpha chain |
chr22_-_30970560 | 2.52 |
ENST00000402369.1
ENST00000406361.1 |
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
chr17_-_64225508 | 1.93 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr19_-_36304201 | 1.93 |
ENST00000301175.3
|
PRODH2
|
proline dehydrogenase (oxidase) 2 |
chr11_+_71934962 | 1.84 |
ENST00000543234.1
|
INPPL1
|
inositol polyphosphate phosphatase-like 1 |
chr9_-_123812542 | 1.79 |
ENST00000223642.1
|
C5
|
complement component 5 |
chr17_-_26697304 | 1.78 |
ENST00000536498.1
|
VTN
|
vitronectin |
chr22_-_30970498 | 1.43 |
ENST00000431313.1
|
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
chr8_-_145754428 | 1.24 |
ENST00000527462.1
ENST00000313465.5 ENST00000524821.1 |
C8orf82
|
chromosome 8 open reading frame 82 |
chr11_-_61687739 | 1.13 |
ENST00000531922.1
ENST00000301773.5 |
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1 |
chr19_-_58864848 | 1.10 |
ENST00000263100.3
|
A1BG
|
alpha-1-B glycoprotein |
chr17_+_4692230 | 1.09 |
ENST00000331264.7
|
GLTPD2
|
glycolipid transfer protein domain containing 2 |
chr20_-_33735070 | 1.00 |
ENST00000374491.3
ENST00000542871.1 ENST00000374492.3 |
EDEM2
|
ER degradation enhancer, mannosidase alpha-like 2 |
chr11_-_559377 | 0.95 |
ENST00000486629.1
|
C11orf35
|
chromosome 11 open reading frame 35 |
chrX_-_110655306 | 0.90 |
ENST00000371993.2
|
DCX
|
doublecortin |
chrX_-_15288154 | 0.85 |
ENST00000380483.3
ENST00000380485.3 ENST00000380488.4 |
ASB9
|
ankyrin repeat and SOCS box containing 9 |
chr19_+_50016610 | 0.82 |
ENST00000596975.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr19_+_54466179 | 0.79 |
ENST00000270458.2
|
CACNG8
|
calcium channel, voltage-dependent, gamma subunit 8 |
chr12_+_54410664 | 0.60 |
ENST00000303406.4
|
HOXC4
|
homeobox C4 |
chr20_+_42187682 | 0.59 |
ENST00000373092.3
ENST00000373077.1 |
SGK2
|
serum/glucocorticoid regulated kinase 2 |
chr19_-_46234119 | 0.57 |
ENST00000317683.3
|
FBXO46
|
F-box protein 46 |
chr14_-_54425475 | 0.53 |
ENST00000559642.1
|
BMP4
|
bone morphogenetic protein 4 |
chr16_+_87636474 | 0.52 |
ENST00000284262.2
|
JPH3
|
junctophilin 3 |
chr7_+_130126012 | 0.51 |
ENST00000341441.5
|
MEST
|
mesoderm specific transcript |
chr20_+_42187608 | 0.43 |
ENST00000373100.1
|
SGK2
|
serum/glucocorticoid regulated kinase 2 |
chr2_-_87248975 | 0.42 |
ENST00000409310.2
ENST00000355705.3 |
PLGLB1
|
plasminogen-like B1 |
chr17_-_26733179 | 0.41 |
ENST00000440501.1
ENST00000321666.5 |
SLC46A1
|
solute carrier family 46 (folate transporter), member 1 |
chr7_-_7575477 | 0.39 |
ENST00000399429.3
|
COL28A1
|
collagen, type XXVIII, alpha 1 |
chr7_+_130126165 | 0.36 |
ENST00000427521.1
ENST00000416162.2 ENST00000378576.4 |
MEST
|
mesoderm specific transcript |
chrX_-_18690210 | 0.36 |
ENST00000379984.3
|
RS1
|
retinoschisin 1 |
chr17_-_39156138 | 0.35 |
ENST00000391587.1
|
KRTAP3-2
|
keratin associated protein 3-2 |
chr3_-_114477787 | 0.34 |
ENST00000464560.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr7_+_150725510 | 0.34 |
ENST00000461373.1
ENST00000358849.4 ENST00000297504.6 ENST00000542328.1 ENST00000498578.1 ENST00000356058.4 ENST00000477719.1 ENST00000477092.1 |
ABCB8
|
ATP-binding cassette, sub-family B (MDR/TAP), member 8 |
chr2_+_105050794 | 0.34 |
ENST00000429464.1
ENST00000414442.1 ENST00000447380.1 |
AC013402.2
|
long intergenic non-protein coding RNA 1102 |
chr3_+_35722424 | 0.30 |
ENST00000396481.2
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
chr22_-_30642728 | 0.29 |
ENST00000403987.3
|
LIF
|
leukemia inhibitory factor |
chr3_+_35722487 | 0.28 |
ENST00000441454.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
chr5_+_60933634 | 0.28 |
ENST00000505642.1
|
C5orf64
|
chromosome 5 open reading frame 64 |
chr2_+_133174147 | 0.28 |
ENST00000329321.3
|
GPR39
|
G protein-coupled receptor 39 |
chr15_+_76352178 | 0.24 |
ENST00000388942.3
|
C15orf27
|
chromosome 15 open reading frame 27 |
chr14_+_39703112 | 0.24 |
ENST00000555143.1
ENST00000280082.3 |
MIA2
|
melanoma inhibitory activity 2 |
chr11_-_74800799 | 0.22 |
ENST00000305159.3
|
OR2AT4
|
olfactory receptor, family 2, subfamily AT, member 4 |
chr3_+_77088989 | 0.22 |
ENST00000461745.1
|
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
chrM_+_9207 | 0.21 |
ENST00000362079.2
|
MT-CO3
|
mitochondrially encoded cytochrome c oxidase III |
chr11_+_8040739 | 0.20 |
ENST00000534099.1
|
TUB
|
tubby bipartite transcription factor |
chr12_+_53835508 | 0.19 |
ENST00000551003.1
ENST00000549068.1 ENST00000549740.1 ENST00000546581.1 ENST00000549581.1 ENST00000541275.1 |
PRR13
PCBP2
|
proline rich 13 poly(rC) binding protein 2 |
chr5_+_140625147 | 0.19 |
ENST00000231173.3
|
PCDHB15
|
protocadherin beta 15 |
chr2_+_190541153 | 0.19 |
ENST00000313581.4
ENST00000438402.2 ENST00000431575.2 ENST00000281412.6 |
ANKAR
|
ankyrin and armadillo repeat containing |
chr1_+_170632250 | 0.18 |
ENST00000367760.3
|
PRRX1
|
paired related homeobox 1 |
chrM_+_10053 | 0.16 |
ENST00000361227.2
|
MT-ND3
|
mitochondrially encoded NADH dehydrogenase 3 |
chrX_+_9431324 | 0.16 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
chr12_+_131438443 | 0.16 |
ENST00000261654.5
|
GPR133
|
G protein-coupled receptor 133 |
chr6_-_116447283 | 0.16 |
ENST00000452729.1
ENST00000243222.4 |
COL10A1
|
collagen, type X, alpha 1 |
chr6_-_152793728 | 0.16 |
ENST00000495090.2
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1 |
chr19_+_926000 | 0.16 |
ENST00000263620.3
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like) |
chr7_+_100026406 | 0.16 |
ENST00000414441.1
|
MEPCE
|
methylphosphate capping enzyme |
chr8_+_98900132 | 0.15 |
ENST00000520016.1
|
MATN2
|
matrilin 2 |
chr14_-_83262540 | 0.15 |
ENST00000554451.1
|
RP11-11K13.1
|
RP11-11K13.1 |
chr7_+_48211048 | 0.15 |
ENST00000435803.1
|
ABCA13
|
ATP-binding cassette, sub-family A (ABC1), member 13 |
chr22_-_30722912 | 0.15 |
ENST00000215790.7
|
TBC1D10A
|
TBC1 domain family, member 10A |
chr12_-_2944184 | 0.14 |
ENST00000337508.4
|
NRIP2
|
nuclear receptor interacting protein 2 |
chr6_-_31681839 | 0.14 |
ENST00000409239.1
ENST00000461287.1 |
LY6G6E
XXbac-BPG32J3.20
|
lymphocyte antigen 6 complex, locus G6E (pseudogene) Uncharacterized protein |
chr12_-_11184006 | 0.13 |
ENST00000390675.2
|
TAS2R31
|
taste receptor, type 2, member 31 |
chr2_-_40680578 | 0.13 |
ENST00000455476.1
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr20_-_21494654 | 0.13 |
ENST00000377142.4
|
NKX2-2
|
NK2 homeobox 2 |
chrY_-_20935572 | 0.13 |
ENST00000382852.1
ENST00000344884.4 ENST00000304790.3 |
HSFY2
|
heat shock transcription factor, Y linked 2 |
chr6_+_161123270 | 0.12 |
ENST00000366924.2
ENST00000308192.9 ENST00000418964.1 |
PLG
|
plasminogen |
chr6_+_25754927 | 0.12 |
ENST00000377905.4
ENST00000439485.2 |
SLC17A4
|
solute carrier family 17, member 4 |
chr4_-_68829226 | 0.12 |
ENST00000396188.2
|
TMPRSS11A
|
transmembrane protease, serine 11A |
chrY_+_20708557 | 0.11 |
ENST00000307393.2
ENST00000309834.4 ENST00000382856.2 |
HSFY1
|
heat shock transcription factor, Y-linked 1 |
chr9_-_95298254 | 0.11 |
ENST00000444490.2
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr3_+_46919235 | 0.11 |
ENST00000449590.1
|
PTH1R
|
parathyroid hormone 1 receptor |
chr4_-_69111401 | 0.11 |
ENST00000332644.5
|
TMPRSS11B
|
transmembrane protease, serine 11B |
chr16_-_15474904 | 0.11 |
ENST00000534094.1
|
NPIPA5
|
nuclear pore complex interacting protein family, member A5 |
chr1_-_160549235 | 0.10 |
ENST00000368054.3
ENST00000368048.3 ENST00000311224.4 ENST00000368051.3 ENST00000534968.1 |
CD84
|
CD84 molecule |
chr9_+_44868935 | 0.10 |
ENST00000448436.2
|
RP11-160N1.10
|
RP11-160N1.10 |
chr20_-_7921090 | 0.09 |
ENST00000378789.3
|
HAO1
|
hydroxyacid oxidase (glycolate oxidase) 1 |
chr6_-_32374900 | 0.09 |
ENST00000374995.3
ENST00000374993.1 ENST00000414363.1 ENST00000540315.1 ENST00000544175.1 ENST00000429232.2 ENST00000454136.3 ENST00000446536.2 |
BTNL2
|
butyrophilin-like 2 (MHC class II associated) |
chr12_+_80750134 | 0.08 |
ENST00000546620.1
|
OTOGL
|
otogelin-like |
chr4_+_3443614 | 0.08 |
ENST00000382774.3
ENST00000511533.1 |
HGFAC
|
HGF activator |
chr6_-_161085291 | 0.07 |
ENST00000316300.5
|
LPA
|
lipoprotein, Lp(a) |
chr11_+_22696314 | 0.06 |
ENST00000532398.1
ENST00000433790.1 |
GAS2
|
growth arrest-specific 2 |
chr9_-_215744 | 0.06 |
ENST00000382387.2
|
C9orf66
|
chromosome 9 open reading frame 66 |
chr7_+_143806607 | 0.06 |
ENST00000408979.2
|
OR2A2
|
olfactory receptor, family 2, subfamily A, member 2 |
chr3_-_49066811 | 0.05 |
ENST00000442157.1
ENST00000326739.4 |
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
chr12_-_10321754 | 0.05 |
ENST00000539518.1
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1 |
chr4_-_149365827 | 0.04 |
ENST00000344721.4
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
chr1_+_63063152 | 0.04 |
ENST00000371129.3
|
ANGPTL3
|
angiopoietin-like 3 |
chr12_-_91546926 | 0.04 |
ENST00000550758.1
|
DCN
|
decorin |
chr1_-_168464875 | 0.03 |
ENST00000422253.1
|
RP5-968D22.3
|
RP5-968D22.3 |
chr22_-_22337204 | 0.03 |
ENST00000430142.1
ENST00000357179.5 |
TOP3B
|
topoisomerase (DNA) III beta |
chr1_-_247921982 | 0.03 |
ENST00000408896.2
|
OR1C1
|
olfactory receptor, family 1, subfamily C, member 1 |
chr9_-_95298314 | 0.03 |
ENST00000344604.5
ENST00000375540.1 |
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr12_+_59989918 | 0.02 |
ENST00000547379.1
ENST00000549465.1 |
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr14_+_23709555 | 0.02 |
ENST00000430154.2
|
C14orf164
|
chromosome 14 open reading frame 164 |
chr14_-_104408645 | 0.02 |
ENST00000557640.1
|
RD3L
|
retinal degeneration 3-like |
chr5_+_118690466 | 0.02 |
ENST00000503646.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr11_-_58378759 | 0.01 |
ENST00000601906.1
|
AP001350.1
|
Uncharacterized protein |
chr14_+_95027772 | 0.01 |
ENST00000555095.1
ENST00000298841.5 ENST00000554220.1 ENST00000553780.1 |
SERPINA4
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
chr4_-_100356551 | 0.00 |
ENST00000209665.4
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr12_+_59989791 | 0.00 |
ENST00000552432.1
|
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr8_+_92114060 | 0.00 |
ENST00000518304.1
|
LRRC69
|
leucine rich repeat containing 69 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.9 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 1.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 1.9 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.3 | 0.8 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.2 | 3.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 1.0 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 1.9 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.5 | GO:2000007 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.1 | 1.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 0.4 | GO:0051958 | methotrexate transport(GO:0051958) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 1.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.2 | GO:0061364 | negative regulation of negative chemotaxis(GO:0050925) apoptotic process involved in luteolysis(GO:0061364) |
0.0 | 0.1 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.0 | 0.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.5 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.8 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 1.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 3.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.9 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.4 | 1.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 3.9 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 1.8 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.4 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.1 | 1.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.0 | 1.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 1.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.5 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.4 | GO:0070492 | phosphatidylinositol-5-phosphate binding(GO:0010314) oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.1 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 0.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 1.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 3.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |